Propanc Biopharma (PPCB) Q4 2025 Earnings

Screener

Reported February 17, 2026 · Before market open

EPS-$0.30

Next report

Date not yet announced

Versus estimates

Revenue

Diluted EPS

Q4 2025-$0.30

Q3 2025-$0.39 Q2 2025-$0.35 Q1 2025-$12.50 Q4 2024-$32.23

FAQ

When did Propanc Biopharma report Q4 2025 earnings?: Propanc Biopharma (PPCB) reported Q4 2025 earnings on February 17, 2026 before market open.
What were Propanc Biopharma's Q4 2025 revenue and EPS?: Propanc Biopharma reported eps of $-0.30 for Q4 2025.
How did Propanc Biopharma's Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, eps grew 99.1% from $-32.23.
Where can I find Propanc Biopharma's Q4 2025 SEC filings?: You can read the 10-Q periodic report (0001493152-26-007052) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Propanc Biopharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk